BIT
INSY

BlackRock Institutional Trust’s Insys Therapeutics, Inc. INSY Stock Holding History

BlackRock Institutional Trust’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.65M Buy
722,882
+51,433
+8% +$581K ﹤0.01% 2618
2016
Q3 		$7.92M Buy
671,449
+26,535
+4% +$403K ﹤0.01% 2479
2016
Q2 		$8.35M Buy
644,914
+56,484
+10% +$823K ﹤0.01% 2398
2016
Q1 		$9.41M Buy
588,430
+24,889
+4% +$473K ﹤0.01% 2297
2015
Q4 		$16.1M Buy
563,541
+8,922
+2% +$247K ﹤0.01% 2008
2015
Q3 		$15.8M Sell
554,619
-85,981
-13% -$3.16M ﹤0.01% 1992
2015
Q2 		$23M Sell
640,600
-4,058
-0.6% -$126K ﹤0.01% 1832
2015
Q1 		$18.7M Sell
644,658
-7,782
-1% -$206K ﹤0.01% 1985
2014
Q4 		$13.8M Sell
652,440
-69,564
-10% -$1.38M ﹤0.01% 2163
2014
Q3 		$14M Buy
722,004
+41,664
+6% +$654K ﹤0.01% 2107
2014
Q2 		$10.6M Buy
680,340
+171,524
+34% +$2.77M ﹤0.01% 2402
2014
Q1 		$10.5M Sell
508,816
-10,886
-2% -$216K ﹤0.01% 2385
2013
Q4 		$6.71M Buy
519,702
+133,281
+34% +$1.85M ﹤0.01% 2653
2013
Q3 		$4.51M Buy
386,421
+198,972
+106% +$1.63M ﹤0.01% 2779
2013
Q2 		$865K Buy
+187,449
New +$687K ﹤0.01% 3365

Other funds holding INSY

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BlackRock Institutional Trust's INSY Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Insys Therapeutics, Inc. (INSY) stake by 7.7% in Q4 2016, buying an estimated $581K and bringing the position to 722,882 shares worth $6.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

BlackRock Institutional Trust first reported a position in INSY in Q2 2013 and has held it in 15 quarters since. The position peaked at $23M in Q2 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • BlackRock Institutional Trust held 722,882 shares of Insys Therapeutics, Inc. worth $6.65M as of Q4 2016.
  • BlackRock Institutional Trust bought 51,433 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $581K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2618 holding.
  • BlackRock Institutional Trust first reported a position in Insys Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Insys Therapeutics, Inc. position peaked at $23M in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.